The CA 125 tumour-associated antigen: A review of the literature

Human Reproduction

Volumn 4, Issue 1, 1989, Pages 1-12

  Jacobs, Ian ^a   Bast, Robert C ^b  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b DUKE CANCER INSTITUTE   (United States)

Author keywords

CA 125; Endometrium; Monoclonal antibody; Ovarian cancer

Indexed keywords

CA 125 ANTIGEN; MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

CONTROLLED STUDY; ENDOMETRIUM; HUMAN; HUMAN CELL; OVARY CANCER; REVIEW;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMAN; OVARIAN NEOPLASMS; PREGNANCY; PROGNOSIS; UTERINE NEOPLASMS;

EID: 0024511529     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a136832     Document Type: Review

References (91)

1. Atack, D. B., Nisker, J. A., Allen, H. H., Tsutanoff, E. R. and Levon, L. (1986) CA 125 surveillance and second-look laparotomy in ovarian carcinoma. Am. J. Obstet. Gynecol., 154, 287-289.
2. Barbieri, R. L. (1987) CA-125 and endometriosis. Contrib. Gynecol. Obstet., 16. 103-108.
3. Barbieri, R. L., Niloff, J. M., Bast, R. C., Schaetzl, R. N., Kistner, R. W. and Knapp, R. C. (1986) Elevated serum concentrations of CA-125 in patients with advanced endometriosis. Fertil. Steril., 45, 630-634.
4. Bast, R. C., Feeney, M., Lazarus, H., Nadler, L., Colvin, R. B. and Knapp, R. C. (1981) Reactivity of a monoclonal antibody with human ovarian carcinoma. J. Clin. Invest., 68, 1331-1337.
5. Bast, R. C., Klug, T. L., St John, E., Jenison, E., Niloff, J. M., Lazarus, H., Berkowitz, R. S., Leavitt, T., Griffiths, C. T., Parker, L., Zurawski, V. R. and Knapp, R. C. (1983) A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N. Engl. J. Med., 309, 169-171.
6. Bell, S. C. (1986) Secretory endometrial and decidual proteins: studies and clinical significance of a maternally derived group of pregnancy associated serum proteins. Hum. Reprod., 1, 129-143.
7. Berek, J. S., Knapp, R. C., Malkasian, G. C., Lavin, P. T., Whitney, C., Niloff, J. M. and Bast, R. C. (1986) CA 125 serum levels correlated with second-look operations among ovarian cancer patients. Obstet. Gynecol., 67, 685-689.
8. Bergmann, J. F., Beaugrand, J. M., Labadie, H., Bidart, J. M. and Bohuon, C.(1986) CA 125 (ovarian tumour-associated antigen) in ascitic liver diseases Clin. Chim. Acta, 155, 163-166.
9. Bergmann, J. F., Bidart, J. M., George, M., Beaugrand, J. M., Levy, V. G. and Bohuon, C. (1987) Elevation of CA 125 in patients with benign and malignant ascites. Cancer, 59, 213-217.
10. Bischof, P., Tseng, L., Brioschi, P. A. and Herrmann, W. L. (1986) Cancer antigen 125 is produced by human endometrial stromal cells. Hum. Reprod., 1, 423-426.
11. Brioschi, P. A., Irion, O., Bischoff, P., Bader, M., Fomi, M. and Krauer, F. (1987) Serum CA125 in epithelial ovarian cancer. A longitudinal study. Br. J. Obstet. Gynecol., 94, 196-201.
12. Canney, P. A., Moore, M., Wilkinson, P. M. and James, R. D. (1984) Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker. Br. J. Cancer, 50, 765-769.
13. Crombach, G. and Wurz, H. (1984) CA 125, TPA and CEA in ovarian cancer-a critical evaluation of single and combined determinations of serum markers. In Geten, H. and Klapdor, R. (eds). New Tumour Associated Antigens. Georg Thieme Verlag, Stuttgart and New York, pp. 134-144.
14. Crombach, G., Zippel, H. H. and Wurz, H. (1985a) Erfahrungen mit CA125, einem Tumormarker fur maligne epitheliale Ovarialetumuren. Geburtshilfe Frauenhildkd., 45, 205-212.
15. Crombach, G., Zippel, H. H. and Wurz, H. (1985b) Clinical significance of cancer antigen 125 (CA125) in ovarian cancer. Cancer Detect. Prev., 8, 135-139.
16. Cruickshank, D. J., Fullerton, W. T. and Klopper, A. (1987) The clinical significance of pre-operative serum CA 125 in ovarian cancer. Br. J. Obstet. Gynaecol., 94, 692-695.
17. Davis, H. M., Zurawski, V. R., Bast, R. C. and Klug, T. L. (1986) Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas. Cancer Res., 46, 6143-6148.
18. de Bruijn, H. W. A., Calkoen-Carpay, T., Jager, S., Duk, J. M., Aalder, J. G. and Fleuren, G. J. (1986) The tumor marker CA 125 is a common constituent of normal cervical mucus. Am. J. Obstet. Gynecol, 154, 1088-1091.
19. Dietel, M., Arps, H., Klapdor, R., Muller-Hagen, S., Sieck, M. and Hoffmann, L. (1986) Antigen detection by the monoclonal antibodies CA19-9 and CA15 in normal and tumor tissue and patients’ sera. J. Cancer Res. Clin. Oncol., 111, 257-265.
20. Duk, J. M., Aalders, J. G., Fleuren, G. J. and de Bruijn, H. W. A. (1986) CA 125: a useful marker in endometrial carcinoma. Am. J. Obstet. Gynecol, 155, 1097-1101.
21. Eerdekens, M. W., Nouwen, E. J., Pollet, D. E., Briers, T. W. and De Broe, M. E. (1985) Placental alkaline phosphatase and cancer antigen 125 in sera of patients with benign and malignant diseases. Clin. Chem., 31, 687-690.
22. Einhom, N., Bast, R. C., Jr, Knapp, R. C., Tjemberg, B. and Zurawski, V. R. (1986) Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer. Obstet. Gynecol., 67, 414-416.
23. Fedele, L., Vercellini, P., Arcaini, L., Grazia de Dalt, M. and Cand iani, G. B. (1988) CA 125 in serum, peritoneal fluid, active lesions, and endometrium of patients with endometriosis. Am. J. Obstet. Gynecol., 158, 166-170.
24. Fish, R. G., Maughan, S. T., Rocker, I. and Adams, M. (1987) The clinical value of serum CA125 levels in ovarian cancer patients receiving platinum therapy. Br. J. Cancer Clin. Oncol., 23, 831-835.
25. Fleuren, G. J., Nap, M., Aalders, J. G., Trimbos, J. B. and de Bruijn, H, W, A. (1987) Explanation of the limited correlation between tumour CA 125 content and serum CA 125 antigen levels in patients with ovarian tumours. Cancer, 60, 2437-2442.
26. Fuith, L. C., Dazenbickler, G. and Dapunt, O. (1987) CA 125 in the serum and tissue of patients with gynecological disease. Arch. Gynecol. Obstet., 241, 157-164.
27. Giudice, L. C., Jacobs, A., Pineda, J., Bell, C. E. and Lippmann, L. (1986) Serum levels of CA-125 in patients with endometriosis: a preliminary report. Fertil. Steril., 45, 876-878.
28. Green, P. J., Balias, S. K., Westkaeper, P., Schwartz, H. G., Klug, T. L. and Zurawski, V. R. (1986) CA 19-9 and CA 125 levels in the sera of normal blood donors in relation to smoking history. J. Natl. Cancer Inst., 77, 337-341.
29. Haga, Y., Sakamoto, K., Egami, H., Yoshimura, R. and Akagi, M. (1986a) Evaluation of serum CA125 values in healthy individuals and pregnant women. Am. J. Med. Sci., 292, 25-29.
30. Haga, Y., Sakamoto, K., Egami, H., Yoshimura, R., Mori, K. and Akagi, M. (1986b) Clinical significance of serum CA125 values in patients with cancers of the digestive system. Am. J. Med. Sci., 292, 30-34.
31. Haglund, C. (1986) Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA. Br. J. Cancer, 54, 897-901.
32. Hulila, H. (1985) Detection of ovarian cancer marker CA 125 in human seminal plasma. Tumor Biol., 6, 207-212.
33. Halila, H., Stenman, U. H. and Seppala, M. (1986) Ovarian cancer antigen CA125 levels in pelvic inflammatory disease and pregnancy. Cancer, 57, 1327-1329.
34. Hanisch, F. G., Uhlenbruck, G., Dienst, C., Stottrop, M. and Hippauf, E.(1988) CA 125 and CA 19-9: two cancer-associated sialylsaccharide antigens on a mucus glycoprotein from human milk. Eur. J. Biochem., 149, 323-330.
35. Heinonen, P. K., Tontti, K., Koivula, T. and Pystynen, P. (1985) Tumour-associated antigen CA 125 in patients with ovarian cancer. Br. J. Obstet. Gynaecol., 37, 2139-2140.
36. Ishiwata, I., Ishiwata, C., Nazawa, S. and Ishikawa, H. (1986) CA125 production by gynaecologic tumours in vitro and its modulation induced by dibutyl cyclic adenosine monophosphate. Asia-Oceania J. Obstet. Gynecol., 12, 285-290.
37. lacobs, I. J., Fay, T. N., Stabile, I., Bridges, J., Oram, D. H. O. and Grudzinskas, J. G. (1988a) The distribution of CA 125 in the reproductive tract of pregnant and non pregnant women. Br. J. Obstet. Gynaecol., 95, 1190-1194.
38. Jacobs, I. J., Stabile, J., Bridges, J., Kemsley, P., Reynolds, C., Grudzinskas, J. G. and Oram, D. H. (1988b) Multimodal approach to screening for ovarian cancer. Lancet, 1, 268-271.
39. Jager, W., Diedrich, K. and Wildt, L. (1987) Elevated levels of CA-125 in serum of patients suffering from ovarian hyperstimulation syndrome. Fertil. Steril., 48, 675-678.
40. Kabawat, S. E., Bast, R. C., Welch, W. R., Knapp, R. C. and Colvin, R. B. (1983a) Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometroid, and clear cell types. Am. J. Clin. Pathol., 79, 98-104.
41. Kabawat, S. E., Bast, R. C., Bhan, A K., Welch, W. R., Knapp, R. C. and Colvin, R. B. (1983b) Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int. J. Gynecol. Pathol., 2, 275-285.
42. Kaesemann, H., Caffier, H., Hoffmann, F. J., Crombach, G., Wurz, H., Kreienberg, R., Mobus, V., Schmidt-Rhode, P. and Sturm, G. (1986) Monoklonale Antikorper in diagnostik und verlaufskontrolle de ovarialkarzinomas. CA 125 als tumormarker. Klin. Wochenshr., 64, 781-785.
43. Karlan, B. Y., Amin, W., Casper, S. E. and Littlefield, B. A. (1988) Hormonal regulation of CA125 tumour marker expression in human ovarian carcinoma cells: inhibition by glucocorticoids. Cancer Res., 48, 3502-3506.
44. Kauppila, A., Telimass, S., Ronnberg, L. and Vuori, J. (1988) Placebo-controlled study on serum concentrations of CA-125 before and after treatment on endometriosis with Danazol or high-dose medroxyprogesterone acetate alone or after surgery. Fertil. Steril., 49, 37-41.
45. Kawahara, M., Teraski, P. I., Chia, D., Johnson, C., Hermes, M. and Tokita, K. (1986) Use of four monoclonal antibodies to detect tumor markers. Cancer, 58, 2008-2012.
46. Khoo, S. K., Hurst, T., Webb, M. J., Dickie, G. J., Kearsley, J. H. and Mackay, E. V. (1987) Predictive value of serial CA 125 antigen levels in ovarian cancer evaluated by second-look laparotomy. Eur. J. Cancer Clin. Oncol., 23, 767-771.
47. Kivinen, S., Kuoppala, T., Leppilampi, M., Vuori, J. and Kauppila, A.(1986) Tumor-associated antigen CA 125 before and during the treatment of ovarian carcinoma. Obstet. Gynecol., 67, 468-472.
48. Klug, T. L., Bast, R. C., Niloff, J. M., Knapp, R. C. and Zurawski, V. R. (1984) Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas. Cancer Res., 44, 1048-1053.
49. Koelma, I. A., Nap, M., Rodenburg, C. J. and Fleuren, G. J. (1987) The value of tumour marker CA 125 in surgical pathology. Histopathology, 11, 287-294.
50. Kohler, G. and Milstein, C. (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature, 256, 495-497.
51. Krebs, H. B., Goplerud, D. R., Kilpatrick, S. J., Myers, M. B. and Hunt, A. (1986) Role of CA 125 as tumor marker in ovarian carcinoma. Obstet. Gynecol., 67, 473-477.
52. Kuzuya, K., Nozaki, M. and Chihara, T. (1986) Evaluation of CA125 as a circulating tumor marker for ovarian cancer. Acta Obstet. Gynaecol. Jap., 38, 949-957.
53. Lambert, J. (1987) The value of CA 125 serum assay in the management of ovarian cancer. Br. J. Obstet. Gynaecol., 94, 193-195.
54. Lan, M. S., Bast, R. C., Colnaughi, M. l., Knapp, R. C., Colcher, D., Schlom, J. and Metzgar, R. S. (1987) Co-expression of human cancer-associated epitopes on mucin molecules. Int. J. Cancer, 39, 69-72.
55. Lavin, P. T., Knapp, R. C., Malkasian, G., Whitney, C. W., Berek, J. and Bast, R. C. (1987) CA 125 for the monitoring of ovarian carcinoma during primary therapy. Obstet. Gynecol., 69, 223-227.
56. Li-juan, L., Xiu-feng, H., Wen-shu, L. and Ai-ju, W. (1986) A monoclonal antibody radioimmunoassay for an antigenic determinant CA125 in ovarian cancer patients. Clin. Med, J., 99, 721-726.
57. Mainguene, C., Aillet, G., Kremer, M. and Chatal, J. F. (1986) Immunohistochemical study of ovarian tumors using the OC 125 monoclonal antibody as a basis for potential in vivo and in vitro applications. J. Nucl. Med., 30, 19-22.
58. Martoni, A., Belluco, A., Marabini, A., Orland i, C., Plate, L., Bianchi, D. and Pannuti, F. (1986) CA 125 monitoring during chemotherapy for ovarian cancer. Int. J. Biol. Markers, 1, 121-128.
59. Mastropaolo, W., Fernand ez, Z. and Miller, E. (1986) Pronounced increases in the concentration of an ovarian tumor marker, CA-125, in serum of a healthy subject during menstruation. Clin. Chem., 32, 2110-2111.
60. Meier, W., Stieber, P., Fateh-Moghadam, A., Eiermann, W. and Hepp, H.(1987) CA-125 in gynecological malignancies. Br. J. Cancer Clin. Oncol., 23, 713-717.
61. Mobus, V., Kreinberg, R., Crombach, G., Wurz, H., Caffier, H., Kaesemann, H., Hoffmann, F. J., Schmidt-Rhode, P., Sturm, G. and Kaufmann, M. (1988) Evaluation of CA 125 as a prognostic and predictive factor in ovarian cancer. J. Tumor Marker Oncol., in press.
62. Niloff, J. M., Thomas, L., Klug, L., Schaetzl, E., Zurawski, V. R., Knapp, R. C. and Bast, R. C. (1984a) Elevation of serum CA125 in carcinomas of the Fallopian tube, endometrium and endocervix. Am. J. Obstet. Gynecol., 148, 1057-1058.
63. Niloff, J. M., Knapp, R. C., Schaetzl, E., Reynolds, C. and Bast, R. C. (1984b) CA125 antigen levels in obstetric and gynecologic patients. Obstet. Gynecol., 64, 703-707.
64. Niloff, J. M., Bast, R. C., Schaetzl, E. M. and Knapp, R. C. (1985) Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer. Am. J. Obstet. Gynecol., 151, 981-986.
65. Nouwen, E. J., Pollet, D. E., Eerdekens, M. W., Hendrix, P. G., Briers, T. W. and De Broe, M. E. (1986) Immunohistochemical localisation of placental alkaline phosphatase, carcinoembryonic antigen 125 in normal and neoplastic human lung. Cancer Res., 46, 866-876.
66. Nouwen, E. J., Hendrix, P. G., Dauwe, S., Eerdekens, M. W. and de Broe, M. E. (1987) Tumor markers in the human ovary and its neoplasms. Am J. Pathol., 126, 230-242.
67. O’Brien, T. J., Hardin, J. W., Bannon, G. A., Norris, J. S. and Quirk, J. G.(1986) CA 125 antigen in human amniotic fluid and fetal membranes. Am. J. Obstet. Gynecol., 155, 50-55.
68. Ozasa, H., Noda, Y. and Mori, T. (1987) Progesterone increases serum CA-125 in endometriosis. Fertil. Steril., 47, 699-701.
69. Pansini, F., Bellinazzi, A., Rainaldi, V., Santoiemma, M., Lenzi, B., Jacobs, M., Mollica, G. and Bagni, B. (1986) Serum CA 125 in ovarian pathology and its variation in ovarian carcinoma after integrated therapy. Gynecol. Obstet. Invest., 21, 47-51.
70. Patsner, B., Mann, W. J., Cohen, H. and Loesch, M. (1988) Predictive value of preoperative serum CA 125 levels in clinically localised and advanced endometrial carcinoma. Am. J. Obstet. Gynecol., 158, 399-402.
71. Patton, P. E., Field, C. S., Harms, R. W. and Coulam, C. B. (1986) CA-125 levels of endometriosis. Fertil. Steril., 45, 770-773.
72. Pittaway, D. E. and Fayez, J, A. (1986) The use of CA-125 in the diagnosis and management of endometriosis. Fertil. Steril., 46, 790-795.
73. Pittaway, D. E. and Fayez, J. A. (1987) Serum CA-125 antigen levels increase during menses. Am. J. Obstet. Gynecol., 156, 75-76.
74. Ricolleau, G., Chatal, J. F., Fumoleau, P., Kremer, M., Douillard, J. Y. and Curtet, C. (1985) Radioimmunoassay of the CA 125 antigen of ovarian carcinomas: advantages compared with CA 19-9 and CEA. Tumour Biol., 5. 151-159.
75. Rome, R. M., Joh, H., Fortune, D. and Cauchi, M. (1987) CA 125 serum levels and secondary laparotomy in epithelial ovarian tumours. Aust. N, Z J. Obstet. Gynaecol., 27, 142-145.
76. Ruibal, A. and Siuriana, R. (1986) Evidence of a relationship between high serum CA 125 and liver failure pattern in cirrhotic patients without ascitis and jaundice. Int. J. Biol., 1, 55-56.
77. Ruibal, A., Encabo, G., Martinez-Miralles, E., Murcia, C., Capdevila, J. A., Salgado, A. and Martinez-Vasquez, J. M. (1984) CA 125 seric levels in non malignant pathologies. Bull. Cancer, 71, 145-148.
78. Schilthuis, M. S., Aalders, J. G., Bouma, J., Kooi, H., Fleuren, G. J., Willemse, P. H. B. and De Bruijn, H. W. A. (1987) Serum CA 125 levels in epithelial ovarian cancer: relation with findings at second-look operations and their role in the detection of tumour recurrence. Br. J. Obstet. Gynaecol., 94, 202-207.
79. Schwartz, P. E., Chambers, S. K. and Chambers, J. T., Gutmann, J., Katopodis, N. and Foemmel, R. (1987) Circulating tumor markers in the monitoring of gynaecologic malignancies. Cancer, 60, 353-361.
80. Seki, K., Kikuchi, Y., Uesato, T. and Kato, K. (1986) Increased serum CA 125 levels during the first trimester of pregnancy. Acta Obstet. Gynecol. Scand., 65. 583-585.
81. Shi, Q. Y., Sakawaki, T., Kasamatsu, T. and Ohkura, H. (1987) Clinical significance of CA 125 and its assessment with an enzyme immunoassay. Asia-Oceania J. Obstet. Gynaecol., 13, 325-333.
82. Shishi, J., Ghazizadeh, M., Oguro, T., Airhara, K. and Araki, T. (1985) Immunohistochemical localization of CA 125 antigen in formalin-fixed paraffin sections of ovarian tumors with the use of Pronase. Am. J. Clin. Pathol., 85, 595-598.
83. Takahashi, K., Shibukawa, T., Moriyama, M., Shirai, T., Kijima, S., Iwanari, O., Matsunaga, I. and Kitao, M. (1986) Clinical usefulness and false-positive results of CA 125 as a tumor marker of ovarian cancer-a study on 674 patients. Jap. J. Surg., 16, 305-310.
84. Takahashi, K., Yamane, Y., Kijima, S., Yoshino, K., Shibukawa, T. and Kitao, M. (1987) CA 125 antigen is an effective diagnostic for external endometriosis. Gynecol. Obstet. Invest., 23, 257-260.
85. VanderBurg, M. E. L., Lammes, F. B., vanPutten, W. L. J. and Stoter, G.(1990) The prognostic value of CA125 half-life in ovarian cancer. Abstract, Am. Soc. Clin. Oncol.
86. Vasilev, S. A., Schaerth, J. B., Campeau, J. and Morrow, C. P. (1988) Serum CA 125 levels in preoperative evaluation of pelvic masses. Obstet. Gynecol., 71, 751-756.
87. Yabushita, H., Masuda, T., Ogawa, A., Nogluchi, M. and Ishihara, M.(1988) Combination assay of CA125, TPA, 1AP, CEA and ferritin in serum for ovarian cancer. Gynecol. Oncol., 29, 66-75.
88. Young, R. C., Decker, D. G., Major, F., Homesley, H. and Ellenberg, S. (1983) Staging laparotomy in early ovarian cancer. J. Am. Med. Assoc., 250, 3072-3076.
89. Zanaboni, F., Vergadoro, F., Presti, M., Gallotti, P., Lombardi, F. and Bolis, G. (1987) Tumor antigen CA 125 as a marker of ovarian epithelial carcinoma. Gynecol. Oncol. 28, 61-67.
90. Zurawski, V. R., Knapp, R. C., Einhom, N., Kenemans, P., Mortel, R., Ohmi, K., Bast, R. C., Ritts, R. E. and Malksian, G. (1988a) An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma. Gynecol. Oncol., 30, 7-14.
91. Zurawski, V. R., Oijaseter, H., And ersen, A. and Jellum, E. (1988b) Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer. Int. J. Cancer, 42, in press.